BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wise C, Pilanthananond M, Perry BF, Alpini G, McNeal M, Glaser SS. Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol 2008; 14(19): 2986-2989 [PMID: 18494047 DOI: 10.3748/wjg.14.2986]
URL: https://www.wjgnet.com/1007-9327/full/v14/i19/2986.htm
Number Citing Articles
1
Chien Peter Chen, Daphne Haas-Kogan. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnosticsExpert Review of Molecular Diagnostics 2010; 10(7): 883 doi: 10.1586/erm.10.76
2
Donatella Marino, Francesco Leone, Giuliana Cavalloni, Celeste Cagnazzo, Massimo Aglietta. Biliary tract carcinomas: From chemotherapy to targeted therapyCritical Reviews in Oncology/Hematology 2013; 85(2): 136 doi: 10.1016/j.critrevonc.2012.06.006
3
David Tougeron, Ginette Fotsing, Veronique Barbu, Michel Beauchant. ABCB4/MDR3 gene mutations and cholangiocarcinomasJournal of Hepatology 2012; 57(2): 467 doi: 10.1016/j.jhep.2012.01.025
4
Jane A. Smith. Clinical Ultrasound2011; : 227 doi: 10.1016/B978-0-7020-3131-1.00014-6
5
Larisa E Vasilieva, Stefanos I Papadhimitriou, Spyros P Dourakis. Modern diagnostic approaches to cholangiocarcinomaHepatobiliary & Pancreatic Diseases International 2012; 11(4): 349 doi: 10.1016/S1499-3872(12)60192-1
6
Eveline Boucher, Marc Pracht, Catherine Roux, Karim Boudjema, Jean-Luc Raoul. Adjuvant treatment after resection of biliary-tract cancer: yes or no?Oncology Reviews 2010; 4(3): 167 doi: 10.1007/s12156-010-0047-y
7
Jonathan Koea. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract2012; : 760 doi: 10.1016/B978-1-4377-1454-8.00050-3
8
Masaru Oota. Two cases of cholangiocarcinoma in diabetes mellitus causing worsening of glycemic control and acute liver dysfunctionJournal of Clinical and Translational Endocrinology: Case Reports 2018; 10: 4 doi: 10.1016/j.jecr.2018.07.001
9
Sungmin Baek, Young-Suk Lee, Hye-Eun Shim, Sik Yoon, Sun-Yong Baek, Bong-Seon Kim, Sae-Ock Oh. Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinomaAnatomy & Cell Biology 2011; 44(3): 204 doi: 10.5115/acb.2011.44.3.204
10
Laddawan Senggunprai, Veerapol Kukongviriyapan, Auemduan Prawan, Upa Kukongviriyapan. Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling PathwayPhytotherapy Research 2014; 28(6): 841 doi: 10.1002/ptr.5061
11
Atsushi Nanashima, Kenichiro Shibata, Toshiyuki Nakayama, Syuichi Tobinaga, Masato Araki, Masaki Kunizaki, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Takeshi Nagayasu, Tsutomu Tagawa. Relationship Between Microvessel Count and Postoperative Survival in Patients with Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology 2009; 16(8): 2123 doi: 10.1245/s10434-009-0494-5
12
Kaelan J. Yao, Salma Jabbour, Niyati Parekh, Yong Lin, Rebecca A. Moss. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics DatabaseBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0527-z
13
James RA Skipworth, John F Timms, Stephen P Pereira. Novel diagnostic and prognostic biomarkers in biliary tract cancerExpert Opinion on Medical Diagnostics 2013; 7(5): 487 doi: 10.1517/17530059.2013.826646
14
M. Cadamuro, L. Fabris, M. Strazzabosco. Studies on Hepatic DisordersOxidative Stress in Applied Basic Research and Clinical Practice 2015; : 309 doi: 10.1007/978-3-319-15539-5_13
15
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 605 doi: 10.1007/978-3-319-26956-6_31
16
Wen-Chih Huang, Chien-Chen Tsai, Chih-Chieh Chan. Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinomaJournal of the Formosan Medical Association 2017; 116(6): 464 doi: 10.1016/j.jfma.2016.07.015
17
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular CarcinogenesisPathology & Oncology Research 2020; 26(1): 3 doi: 10.1007/s12253-018-0491-8
18
M. Fatima Leite, Mateus T. Guerra, Viviane A. Andrade, Michael H. Nathanson. Signaling Pathways in Liver Diseases2015; : 15 doi: 10.1002/9781118663387.ch2
19
Pokpong Prayong, Eimorn Mairiang, Chawalit Pairojkul, Yaovalux Chamgramol, Pisaln Mairiang, Vajarabhongsa Bhudisawasdi, Banchob Sripa. An Interleukin-6 Receptor Polymorphism is Associated with Opisthorchiasis-Linked Cholangiocarcinoma Risk in ThailandAsian Pacific Journal of Cancer Prevention 2014; 15(13): 5443 doi: 10.7314/APJCP.2014.15.13.5443
20
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
21
M. Fatima Leite, Viviane A. Andrade, Michael H. Nathanson. Signaling Pathways in Liver Diseases2010; : 25 doi: 10.1007/978-3-642-00150-5_2
22
Alessandra Gentilini, Krista Rombouts, Sara Galastri, Alessandra Caligiuri, Eleonora Mingarelli, Tommaso Mello, Fabio Marra, Stefano Mantero, Massimo Roncalli, Pietro Invernizzi, Massimo Pinzani. Role of the stromal-derived factor-1 (SDF-1)–CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinomaJournal of Hepatology 2012; 57(4): 813 doi: 10.1016/j.jhep.2012.06.012
23
Shahid G. Farid, Gareth Morris-Stiff. “OMICS” technologies and their role in foregut primary malignanciesCurrent Problems in Surgery 2015; 52(10): 409 doi: 10.1067/j.cpsurg.2015.08.001
24
Ahmed Abdel-Razik, Youssif ElMahdy, Ehab El hanafy, Rania Elhelaly, Rasha Elzehery, Ahmed M. Tawfik, Waleed Eldars. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary ObstructionsThe American Journal of the Medical Sciences 2016; 351(3): 259 doi: 10.1016/j.amjms.2015.12.013
25
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biologyFrontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
26
Thorsten Lieke, Wolf Ramackers, Sabine Bergmann, Jürgen Klempnauer, Michael Winkler, Johannes Klose. Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitroBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-466
27
J. Munding, A. Tannapfel. Anatomisch-pathologische Besonderheiten der Klatskin-TumorenDer Chirurg 2012; 83(3): 208 doi: 10.1007/s00104-011-2175-8
28
Ijeoma A. Azodo, Rowan W. Parks, O. James Garden. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 1 doi: 10.1007/978-3-642-40558-7_1
29
Robert de W Marsh, Marc Alonzo, Shailesh Bajaj, Marshall Baker, Eric Elton, Thomas A Farrell, Richard M Gore, Curtis Hall, Jan Nowak, Hemant Roy, Arif Shaikh, Mark S. Talamonti. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. PART I: Diagnosis‐clinical staging and pathologyJournal of Surgical Oncology 2012; 106(3): 332 doi: 10.1002/jso.23028
30
Fan Zhang, Lianhong Li, Xingwu Yang, Bo Wang, Jinyao Zhao, Shilun Lu, Xiaotang Yu. Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3’-methyl-4 dimethylaminoazobenzene in ratsJournal of Toxicologic Pathology 2015; 28(2): 79 doi: 10.1293/tox.2014-0047
31
Piotr Milkiewicz, Ewa Wunsch. Inflammation and Gastrointestinal CancersRecent Results in Cancer Research 2011; 185: 117 doi: 10.1007/978-3-642-03503-6_7
32
KUSUMAWADEE UTISPAN, JUMAPORN SONONGBUA, PETI THUWAJIT, SIRI CHAU-IN, CHAWALIT PAIROJKUL, SOPIT WONGKHAM, CHANITRA THUWAJIT. Periostin activates integrin α5β1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinomaInternational Journal of Oncology 2012; 41(3): 1110 doi: 10.3892/ijo.2012.1530
33
Chen Li, Weixing Shen, Sheng Shen, Zhilong Ai. Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinomaComputational Biology and Chemistry 2013; 47: 192 doi: 10.1016/j.compbiolchem.2013.08.010
34
Trevor A. Flood, Dhanpat Jain, E. Celia Marginean. Malignant tumours of gallbladder and extrahepatic bile ductsDiagnostic Histopathology 2010; 16(8): 360 doi: 10.1016/j.mpdhp.2010.06.003
35
Ilkay Kosar, Hilmi Ataseven, Özlem Yönem, Erol Çakmak, Özdemir Özer, Hatice Özer, Ömer Topçu. A new variant of bile duct duplication with coexistence of distal cholangiocarcinomaNature Reviews Gastroenterology & Hepatology 2010; 7(9): 527 doi: 10.1038/nrgastro.2010.118
36
Noppadol Larbcharoensub, Pattana Sornmayura, Ekaphop Sirachainan, Chumpon Wilasrusmee, Harirak Wanmoung, Tavan Janvilisri. Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinomaHistopathology 2011; 59(2): 235 doi: 10.1111/j.1365-2559.2011.03935.x
37
S. DeMorrow. Cholangiocarcinoma: Estrogen-induced autocrine effects of VEGF on cell proliferationDigestive and Liver Disease 2009; 41(2): 164 doi: 10.1016/j.dld.2008.11.005
38
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectivesDigestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
39
Jun Li, Chaochen Zhao, Yuechun Shen. Autoimmune cholangitis and cholangiocarcinomaJournal of Gastroenterology and Hepatology 2012; 27(12): 1783 doi: 10.1111/j.1440-1746.2012.07287.x
40
Kheman Rajkomar, Jonathan B. Koea. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 805 doi: 10.1016/B978-0-323-34062-5.00050-9
41
Anisha Kulkarni, Justin S. Gundara, Anthony J. Gill, Thomas J. Hugh, Jaswinder S. Samra. Cholangiocarcinoma following external beam radiotherapy: A report of two casesOncology Letters 2017; 14(1): 423 doi: 10.3892/ol.2017.6113
42
Baiyin Zhong, Qicheng Liao, Xin Wang, Xiaonong Wang, Jianhong Zhang. The roles of epigenetic regulation in cholangiocarcinogenesisBiomedicine & Pharmacotherapy 2023; 166: 115290 doi: 10.1016/j.biopha.2023.115290